Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 31 May 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 89 positions. The ten largest identified positions carry 34.7% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Alkermes Plc ALKS | Healthcare | Ireland | 4.47% | $7.24M |
| 2 | Kymera Therapeutics Inc KYMR | Healthcare | United States | 4.23% | $6.85M |
| 3 | Celcuity Inc CELC | Healthcare | United States | 3.91% | $6.33M |
| 4 | Mirum Pharmaceuticals Inc MIRM | Healthcare | United States | 3.90% | $6.31M |
| 5 | Spyre Therapeutics Inc SYRE | Healthcare | United States | 3.67% | $5.95M |
| 6 | Cg Oncology Inc CGON | Healthcare | United States | 3.35% | $5.42M |
Source: SEC filings. Information and analytics, not investment advice.